Anthropic CEO Dario Amodei states that artificial intelligence could cure most diseases within the next ten years. This vision is outlined in his 2024 essay « Machines of Loving Grace. » While no AI-designed drug has received full regulatory approval yet, Anthropic has launched an AI drug-discovery program focused on neglected diseases. Prediction markets now price Anthropic’s valuation reaching $1.25 trillion by year-end, with odds rising from 15% to 29.5% in one week.
Source: Read the original article
